Identifying neurodevelopmental conditions like autism and ADHD often takes time due to limited access to specialists and fragmented processes, hindering early intervention. Gabify, founded in 2023, addresses this challenge with an innovative AI-driven platform designed for the early screening and therapy management of speech and neurodevelopmental disorders. The platform leverages advanced voice and vision-based AI to analyze over 189 clinically validated parameters, including speech patterns, facial expressions, eye movement, and behavioral indicators, all aligned with global diagnostic frameworks. Gabify employs a human-in-the-loop approach, where clinical experts verify AI outputs, ensuring assessment accuracy. This system can reduce assessment time by up to 70%, enabling clinicians to serve more patients while upholding high clinical standards. Successfully tested in over 35 preschool and daycare centers in India during its private beta phase, Gabify is poised to revolutionize early intervention strategies in healthcare.
Source link
Share
Read more